Feasibility of using quinine, a potential multidrug resistance-reversing agent, in combination with mitoxantrone and cytarabine for the treatment of acute leukemia

Journal of Clinical Oncology

Volumn 10, Issue 11, 1992, Pages 1730-1736

  Solary, E ^a   Caillot, D ^a   Chauffert, B ^a   Casasnovas, R O ^a   Dumas, M ^a   Maynadie, M ^a   Guy, H ^a  

^a HÔPITAL DU BOCAGE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BILIRUBIN; CYTARABINE; GLYCOPROTEIN P; MITOXANTRONE; QUININE FORMATE;

ACUTE LEUKEMIA; ADOLESCENT; ADULT; AGED; ALOPECIA; ARTICLE; BONE MARROW SUPPRESSION; BRADYCARDIA; CANCER REGRESSION; CANCER RESISTANCE; CLINICAL ARTICLE; FEMALE; GRANULOCYTOPENIA; HEARING LOSS; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LEUKOPENIA; LIVER TOXICITY; MALE; MUCOSA INFLAMMATION; MULTIDRUG RESISTANCE; NAUSEA; PRIORITY JOURNAL; SUPRAVENTRICULAR TACHYCARDIA; THROMBOCYTOPENIA; TINNITUS; VERTIGO; VOMITING;

EID: 0027082717     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1992.10.11.1730     Document Type: Article

References (0)